| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |